- Trials with a EudraCT protocol (32)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
32 result(s) found for: Immunologic Deficiency Syndromes.
Displaying page 1 of 2.
EudraCT Number: 2012-001766-15 | Sponsor Protocol Number: MBL2012 | Start Date*: 2013-02-12 | ||||||||||||||||
Sponsor Name:Fundación Pública Andaluza para la Gestion de la Investigación en Salud de Sevilla | ||||||||||||||||||
Full Title: Impact of azithromycin as an immunomodulator in patients with recurrent pneumonia and deficit of mannose-binding LECITHIN (MBL2012) | ||||||||||||||||||
Medical condition: Pediatric patients with recurrent pneumonia and MBL deficiency. | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | |||||||||||||||||
Trial protocol: ES (Completed) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001480-36 | Sponsor Protocol Number: 2015_31 | Start Date*: 2016-07-11 | |||||||||||
Sponsor Name:Centre Hospitalier Régional et Universitaire de Lille | |||||||||||||
Full Title: Assessment of the IgG trough level in subjects with primary immunodeficiency switching from standard subcutaneous immunoglobulin (SCIG) to every other week HyQvia | |||||||||||||
Medical condition: Primary immunodeficiencies | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-000669-21 | Sponsor Protocol Number: ML18243 | Start Date*: 2005-04-26 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: Pilot study of HIV Viral slope in naive patients treated with Enfuvirtide (ENF) based therapy compared to current standard treatment. | |||||||||||||
Medical condition: advanced HIV management | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-003842-18 | Sponsor Protocol Number: OTL-103-4 | Start Date*: 2019-01-08 | |||||||||||
Sponsor Name:Orchard Therapeutics Ltd. | |||||||||||||
Full Title: A Single Arm, Open Label Clinical Study of Haematopoietic Stem Cell Gene Therapy with Cryopreserved Autologous CD34+ Cells Transduced with Lentiviral Vector encoding WAS cDNA in Subjects with Wisko... | |||||||||||||
Medical condition: Wiskott-Aldrich Syndrome | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2009-017346-32 | Sponsor Protocol Number: 201228 | Start Date*: 2010-03-15 | |||||||||||
Sponsor Name:Fondazione Telethon | |||||||||||||
Full Title: A PHASE I/II CLINICAL TRIAL OF HAEMATOPOIETIC STEM CELL GENE THERAPY FOR THE WISKOTT-ALDRICH SYNDROME | |||||||||||||
Medical condition: Wiskott-Aldrich Syndrom | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18, Adults | Gender: Male | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019518-25 | Sponsor Protocol Number: MENHIR | Start Date*: 2010-06-11 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA "OSPEDALI RIUNITI DI BERGAMO" (A.O. DI RILIEVO NAZIONALE) | |||||||||||||
Full Title: (Maraviroc ENHancement of Immunological Response): A pilot study of maraviroc as an add-on in patients with reduced CD4 cell count despite full viral suppression | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-006188-35 | Sponsor Protocol Number: IMMUNEF | Start Date*: 2009-01-29 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SAN GERARDO DI MONZA | |||||||||||||
Full Title: Immunological efficacy of efavirenz based treatment in HIV-positive naive patients (a pylot study) | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007882-19 | Sponsor Protocol Number: MI2-STAR2-2006 | Start Date*: 2006-10-09 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: A pilot, randomized trial to evaluate the lipid profile after antiretroviral regimens including nevirapine or atazanavir boosted with ritonavir in HIV-positive patients naive for antiretrovirals | |||||||||||||
Medical condition: immunodefic syndrome - patients naive antiretroviral therapy | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001681-16 | Sponsor Protocol Number: Break | Start Date*: 2006-06-06 | |||||||||||
Sponsor Name:FONDAZIONE NADIR ONLUS | |||||||||||||
Full Title: A pilot, open label, randomised clinical trial assessing the 12 week immunological response in HIV-1 failing subjects receiving monotherapy with emtricitabine 200 mg once a day or emtricitabine 200... | |||||||||||||
Medical condition: HIV-Infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007934-21 | Sponsor Protocol Number: MI2-INCA-2007 | Start Date*: 2007-06-27 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: Intracellular concentration of Antiretrovirals)INCA STADY | |||||||||||||
Medical condition: HIV -immunodefic syndrome- | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-004646-29 | Sponsor Protocol Number: GESIDA9016 | Start Date*: 2017-05-31 | |||||||||||
Sponsor Name:Fundación SEIMC-GESIDA | |||||||||||||
Full Title: A phase IV open- label, randomized and pilot clinical trial, designed to evaluate the potential neurotoxicity of dolutegravir/lamivudine/abacavir in neurosymptomatic HIV patients and their reversi... | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001621-26 | Sponsor Protocol Number: MALINFITA006 | Start Date*: 2006-03-13 | |||||||||||
Sponsor Name:A.U.S.L. RIMINI | |||||||||||||
Full Title: A RANDOMIZED, MULTICENTER STUDY OF USE INTERMITTENT HAART HIGHLY ACTIVE ANTIRETROVIRAL THERAPY THERAPY VERSUS CONTINUATIVE HAART THERAPY IN HIV PATIENTS | |||||||||||||
Medical condition: PATIENTS POSITIVE HIV TO LOW RISK OF DEVELOPMENT OF OPPORTUNISTIC PATHOLOGIES CORRELATED-HIV. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-007935-14 | Sponsor Protocol Number: MI2-RIFART-2005 | Start Date*: 2005-03-15 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA | |||||||||||||
Full Title: RIFART | |||||||||||||
Medical condition: HIV- TB | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001158-82 | Sponsor Protocol Number: GESIDA10418 | Start Date*: 2018-09-21 | |||||||||||
Sponsor Name:Fundación SEIMC-GESIDA | |||||||||||||
Full Title: Phase IV, Open Label, Randomized, Clinical Trial to Evaluate the Reversibility of abacavir/lamivudine/dolutegravir CNS-Related Neurotoxicity After Switching to tenofovir alafenamide/emtricitabine/d... | |||||||||||||
Medical condition: HIV | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-002582-39 | Sponsor Protocol Number: NADIR-02 | Start Date*: 2006-07-10 | |||||||||||
Sponsor Name:FONDAZIONE NADIR ONLUS | |||||||||||||
Full Title: A multicenter, randomized, prospective, controlled study to evaluate the efficacy and the tolerability of a switch to a two different-dosed, nevirapine-based HAARTs in HIV-1 infected patients with ... | |||||||||||||
Medical condition: pazienti HIV-1 positivi | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2005-002818-38 | Sponsor Protocol Number: ML 19326 | Start Date*: 2005-07-21 | |||||||||||
Sponsor Name:ROCHE | |||||||||||||
Full Title: ESPrES 500 - Evaluation of the safety profile of the new 500 mg film-coated tablet (FCT) formulation of boosted saquinavir (Invirase 500 mg) in HIV-1 infected patients | |||||||||||||
Medical condition: HIV-! / AIDS | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2014-000307-26 | Sponsor Protocol Number: CeTMAd-VIH-2014 | Start Date*: 2016-06-09 | |||||||||||
Sponsor Name:Iniciativa Andaluza en Terapias Avanzadas-Fundación Pública Andaluza Progreso y Salud | |||||||||||||
Full Title: Clinical trial Phase I/II, test of concept, double blind, randomized, controlled with placebo, to evalue the safety and efficiency of the treatment with expanded adult mesenchymal stem cells from a... | |||||||||||||
Medical condition: Infection for HIV with controlled viral load and immunological discordant response | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003290-15 | Sponsor Protocol Number: GTI1503 | Start Date*: 2016-05-12 | |||||||||||||||||||||
Sponsor Name:Grifols Therapeutics Inc. | |||||||||||||||||||||||
Full Title: A Multi-Centre, Open-Label, Single Arm Trial to Evaluate Efficacy, Pharmacokinetics, and Safety and Tolerability of IGSC 20% in Subjects with Primary Immunodeficiency | |||||||||||||||||||||||
Medical condition: Primary Immunodeficiency (PI) diseases | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Children, Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: GB (Completed) CZ (Completed) ES (Completed) DE (Completed) PL (Completed) HU (Completed) FR (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2017-004137-91 | Sponsor Protocol Number: Gesida92016 | Start Date*: 2018-01-23 | |||||||||||
Sponsor Name:Fundacion SEIMC-GESIDA | |||||||||||||
Full Title: A single-arm, open-label, multicenter phase IV trial to evaluate the efficacy and safety of elvitegravir / cobicistat / emtricitabine / tenofovir alfa-namide as first-line treatment in naïve patien... | |||||||||||||
Medical condition: AIDS | |||||||||||||
|
|||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-000515-14 | Sponsor Protocol Number: GESIDA8014 | Start Date*: 2014-06-26 | |||||||||||
Sponsor Name:Fundación SEIMC-GESIDA | |||||||||||||
Full Title: Comparative, randomized, open study to evaluate maintenance with Darunavir/ritonavir once daily plus Lamivudine once daily versus continuing Darunavir/ritonavir once-daily plus Tenofovir/Emtricitab... | |||||||||||||
Medical condition: HIV chronic infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Completed) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.